Skip to main content

PROAIR RESPICLICK

SABA DPI

Albuterol sulfate · Teva Pharmaceuticals

Clinical Reference · Data reviewed June 2026

Active Medication & Mechanism

  • Albuterol sulfate SABA
    90 mcg albuterol per inhalation

    Short-acting beta2-adrenergic agonist. Produces rapid bronchodilation by relaxing airway smooth muscle via beta2-receptor activation.

FDA-Approved Dosing — Strength × Indication

90 mcg
Asthma FDA Approved
2 inhalations every 4–6 hours as needed → As needed; 1 inhalation may suffice Treatment or prevention of bronchospasm in adults with reversible obstructive airway disease.
Exercise-Induced Bronchospasm FDA Approved
2 inhalations 15–30 minutes before exercise → As needed Prevention of exercise-induced bronchospasm.

All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling

Rescue inhaler. Indicated for acute bronchospasm and as-needed symptom relief — onset within minutes. Increasing or frequent use signals worsening asthma control and warrants controller therapy reassessment.

Related Inhalers

For educational reference by healthcare professionals. Not medical advice and not for use in clinical decision-making. This workspace is not a substitute for clinical judgement, prescribing information, or product monographs — always verify doses and indications against the most current labelling. If you are a patient, do not use this site to make medication decisions — speak with your clinician.

Device images are original illustrations for identification aid only — actual devices and packaging may differ. This site is not affiliated with or endorsed by any pharmaceutical manufacturer. Clinical data last reviewed: June 2026.

Inhaler Database · © inhalerdatabase.com 2024–2026 — All rights reserved